727 related articles for article (PubMed ID: 15919938)
1. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
[TBL] [Abstract][Full Text] [Related]
3. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
Edghill-Smith Y; Bray M; Whitehouse CA; Miller D; Mucker E; Manischewitz J; King LR; Robert-Guroff M; Hryniewicz A; Venzon D; Meseda C; Weir J; Nalca A; Livingston V; Wells J; Lewis MG; Huggins J; Zwiers SH; Golding H; Franchini G
J Infect Dis; 2005 Feb; 191(3):372-81. PubMed ID: 15633096
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
5. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
[TBL] [Abstract][Full Text] [Related]
6. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
[TBL] [Abstract][Full Text] [Related]
7. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
[TBL] [Abstract][Full Text] [Related]
8. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
[TBL] [Abstract][Full Text] [Related]
9. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
10. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
11. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
Edghill-Smith Y; Golding H; Manischewitz J; King LR; Scott D; Bray M; Nalca A; Hooper JW; Whitehouse CA; Schmitz JE; Reimann KA; Franchini G
Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
[TBL] [Abstract][Full Text] [Related]
12. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
13. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
[TBL] [Abstract][Full Text] [Related]
14. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
Nigam P; Earl PL; Americo JL; Sharma S; Wyatt LS; Edghill-Spano Y; Chennareddi LS; Silvera P; Moss B; Robinson HL; Amara RR
Virology; 2007 Sep; 366(1):73-83. PubMed ID: 17507071
[TBL] [Abstract][Full Text] [Related]
15. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
[TBL] [Abstract][Full Text] [Related]
16. Subunit recombinant vaccine protects against monkeypox.
Heraud JM; Edghill-Smith Y; Ayala V; Kalisz I; Parrino J; Kalyanaraman VS; Manischewitz J; King LR; Hryniewicz A; Trindade CJ; Hassett M; Tsai WP; Venzon D; Nalca A; Vaccari M; Silvera P; Bray M; Graham BS; Golding H; Hooper JW; Franchini G
J Immunol; 2006 Aug; 177(4):2552-64. PubMed ID: 16888017
[TBL] [Abstract][Full Text] [Related]
17. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
[TBL] [Abstract][Full Text] [Related]
18. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
[TBL] [Abstract][Full Text] [Related]
20. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques.
Goff AJ; Chapman J; Foster C; Wlazlowski C; Shamblin J; Lin K; Kreiselmeier N; Mucker E; Paragas J; Lawler J; Hensley L
J Virol; 2011 May; 85(10):4898-909. PubMed ID: 21389129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
